Cargando…

High-Throughput Mutation Profiling Changes before and 3 Weeks after Chemotherapy in Newly Diagnosed Breast Cancer Patients

BACKGROUND: Changes in tumor DNA mutation status during chemotherapy can provide insights into tumor biology and drug resistance. The purpose of this study is to analyse the presence or absence of mutations in cancer-related genes using baseline breast tumor samples and those obtained after exposure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Sing-Huang, Sapari, Nur Sabrina, Miao, Hui, Hartman, Mikael, Loh, Marie, Chng, Wee-Joo, Iau, Philip, Buhari, Shaik Ahmad, Soong, Richie, Lee, Soo-Chin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667877/ https://www.ncbi.nlm.nih.gov/pubmed/26630576 http://dx.doi.org/10.1371/journal.pone.0142466

Ejemplares similares

Clinical Potential of DNA Methylation in Gastric Cancer: A Meta-Analysis
por: Sapari, Nur Sabrina, et al.
Publicado: (2012)

High expression of intratumoral stromal proteins is associated with chemotherapy resistance in breast cancer
por: Wang, Tingting, et al.
Publicado: (2016)

Accelerated partial breast irradiation in an Asian population: dosimetric findings and preliminary results of a multicatheter interstitial program
por: Koh, Yaling Vicky, et al.
Publicado: (2016)

Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer
por: Bhattacharya, Bhaskar, et al.
Publicado: (2016)

DNA methylation subgroups and the CpG island methylator phenotype in gastric cancer: a comprehensive profiling approach
por: Loh, Marie, et al.
Publicado: (2014)

Standard 6-week chemoradiation for elderly patients with newly diagnosed glioblastoma
por: Vaugier, Loïg, et al.
Publicado: (2021)

Radiotherapy for Newly Diagnosed Glioblastoma in the Elderly: What Is the Standard?
por: Wee, Chan Woo
Publicado: (2022)

Twice‐weekly ixazomib in combination with lenalidomide‐dexamethasone in patients with newly diagnosed multiple myeloma
por: Richardson, Paul G., et al.
Publicado: (2018)

Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Reduced Weekly Subcutaneous Doses of Bortezomib in Combination with Cyclophosphamide and Dexamethasone for Newly Diagnosed Multiple Myeloma
por: Ashrafi, Farzaneh, et al.
Publicado: (2020)

Multi-catheter interstitial accelerated partial breast irradiation – tips and tricks for a good insertion
por: Tang, Johann I., et al.
Publicado: (2014)

In response to: “Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic”
por: Cimbek, Emine Ayça, et al.
Publicado: (2022)

Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma
por: Albert, Nathalie L., et al.
Publicado: (2023)

Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer
por: Nishio, Shin, et al.
Publicado: (2017)

Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI
por: Lee, Lawrence Soon-U, et al.
Publicado: (2016)

Comparison between newly diagnosed hypertension in diabetes and newly diagnosed diabetes in hypertension
por: Liu, Chang-Yuan, et al.
Publicado: (2019)

Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study
por: Navarria, Pierina, et al.
Publicado: (2017)

Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancer
por: Wong, Andrea L.A., et al.
Publicado: (2016)

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma
por: Dimopoulos, Meletios A., et al.
Publicado: (2020)

Tumor Drug Concentration and Phosphoproteomic Profiles After Two Weeks of Treatment With Sunitinib in Patients with Newly Diagnosed Glioblastoma
por: van Linde, Myra E., et al.
Publicado: (2022)

B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathies
por: Anang, Dornatien C, et al.
Publicado: (2022)

Once-weekly versus twice-weekly carfilzomib in patients with newly diagnosed multiple myeloma: a pooled analysis of two phase I/II studies
por: Bringhen, Sara, et al.
Publicado: (2019)

Insulin Oedema in Newly Diagnosed Type 1 Diabetes Mellitus
por: Baş, Veysel Nijat, et al.
Publicado: (2010)

Characteristics of Children with Newly Diagnosed Type 1 Diabetes Mellitus in Brunei Darussalam
por: Wee, Chun Yen, et al.
Publicado: (2023)

An evaluation of overall survival in patients with newly diagnosed acute myeloid leukemia and the relationship with glasdegib treatment and exposure
por: Lin, Swan, et al.
Publicado: (2020)

Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021)

Ethnic Differences in Survival after Breast Cancer in South East Asia
por: Bhoo-Pathy, Nirmala, et al.
Publicado: (2012)

Neurodevelopmental disorders and somatic diagnoses in a national cohort of children born before 24 weeks of gestation
por: Morsing, Eva, et al.
Publicado: (2022)

INITIAL – An observational study of disease severity in newly diagnosed asthma patients and initial response following 12 weeks’ treatment
por: Lin, Jiangtao, et al.
Publicado: (2019)

Magnetic Resonance Imaging-Based Radiomic Profiles Predict Patient Prognosis in Newly Diagnosed Glioblastoma Before Therapy
por: McGarry, Sean D., et al.
Publicado: (2016)

Determinants of Newly-Diagnosed Raised Blood Pressure: The Malaysian Context
por: LIM, Ooi Wei, et al.
Publicado: (2021)

Clinical and Biological Implications of MYC Activation: A common difference between MGUS and newly diagnosed multiple myeloma
por: Chng, WJ, et al.
Publicado: (2011)

Once-weekly bortezomib had similar effectiveness and lower thrombocytopenia occurrence compared with twice-weekly bortezomib regimen in treating patients with newly diagnosed multiple myeloma in China
por: Yao, Rongxin, et al.
Publicado: (2019)

Extended Family History of Type 1 Diabetes and Phenotype and Genotype of Newly Diagnosed Children
por: Parkkola, Anna, et al.
Publicado: (2013)

A case of newly diagnosed immune thrombocytopenia in the COVID-19 era
por: Clerici, Bianca, et al.
Publicado: (2020)

A phase 1b study of once‐weekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma
por: Alsina, Melissa, et al.
Publicado: (2020)

Effects of a 13-Week Personalized Lifestyle Intervention Based on the Diabetes Subtype for People with Newly Diagnosed Type 2 Diabetes
por: de Hoogh, Iris M., et al.
Publicado: (2022)

Betel nut chewing and incidence of newly diagnosed type 2 diabetes mellitus in Taiwan.
por: Tseng, Chin-Hsiao
Publicado: (2010)

Newly Diagnosed Acute Promyelocytic Leukemia
por: Avvisati, Giuseppe
Publicado: (2011)

Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_c1svkm1ebhl9qnekt63qi2pnpp